DEBBANE RAYMOND bought LXRX
February 25, 2026 · Form 4 insider transaction
DEBBANE RAYMOND bought 2,000 shares of Lexicon Pharmaceuticals, Inc. at $1.49 per share, a transaction worth $3.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,000
Price
$1.49
Total value
$3.0K
InsiderDEBBANE RAYMOND
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateFebruary 25, 2026
Filing dateFebruary 27, 2026
Shares owned after1,906,186
OwnershipDirect
10b5-1 planNo
AmendedNo